Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

CDC: Don’t vape, especially THC

Publish date:: October 22, 2019

Key clinical point: The exact cause of EVALI remains unknown.

Major finding: THC-containing product use was reported by 92% of patients during the 3 months preceding illness.

Study details: Interview of 53/83 EVALI patients in Utah Aug.-Oct. 2019.

Disclosures: The authors reported that they had no conflicts.

Citation:

Lewis N et al. MMWR Morb Mortal Wkly Rep. Early Release. Oct. 22, 2019. 68:1-5.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Pulmonology

E-cigarette use tied to increased COPD, asthma risk,

Obesity, hypoxia predict severity in children with COVID-19,

Telehealth finds acceptance among patients with CF, clinicians,

COVID-19 burdens follow patients after discharge,

Poverty raises depression risk in patients with cystic fibrosis,